Meal intake increases circulating procoagulant microparticles in patients with type 1 and type 2 diabetes mellitus

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Platelets

• Publication date

  2019-04-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/09537104.2018.1445837PMID 29547014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 6. Glycemic Targets: Standards of Medical Care in Diabetes—2018

  2017cited by this paper
• Combined Interval Training and Post-exercise Nutrition in Type 2 Diabetes: A Randomized Control Trial

  2017cited by this paper
• Meal-induced platelet activation in diabetes mellitus type 1 or type 2 is related to postprandial insulin rather than glucose levels.

  2016cited by this paper
• The diversity of platelet microparticles

  2015cited by this paper
• Contact activation: important to consider when measuring the contribution of tissue factor‐bearing microparticles to thrombin generation using phospholipid‐containing reagents

  2014cited by this paper
• Platelets do not express the oxidized or reduced forms of tissue factor.

  2014cited by this paper
• Effect of Lipopolysaccharide Administration on the Number, Phenotype and Content of Nuclear Molecules in Blood Microparticles of Normal Human Subjects

  2013cited by this paper
• Platelet tissue factor: to be or not to be.

  2013cited by this paper
• Prognostic role of plasma von Willebrand factor and soluble E‐selectin levels for future cardiovascular events in a ‘real‐world’ community cohort of patients with atrial fibrillation

  2013cited by this paper
• Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles.

  2012influential reference
• Postprandial changes in the phospholipid composition of circulating microparticles are not associated with coagulation activation.

  2012cited by this paper
• Postprandial Platelet Activation Is Related to Postprandial Plasma Insulin Rather Than Glucose in Patients With Type 2 Diabetes

  2012influential reference
• Platelet‐ and erythrocyte‐derived microparticles trigger thrombin generation via factor XIIa

  2012cited by this paper
• Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study.

  2012cited by this paper
• Microparticles in Hemostasis and Thrombosis

  2011cited by this paper
• Standards of Medical Care in Diabetes—2012

  2011cited by this paper
• Microparticles, Vascular Function, and Atherothrombosis

  2011cited by this paper
• Tissue Factor–Bearing Microparticles and Thrombus Formation

  2011cited by this paper
• Involvement of microparticles in diabetic vascular complications

  2011cited by this paper
• Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay

  2011cited by this paper
• Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease

  2011cited by this paper
• Influence of a light meal on routine haematological tests.

  2010cited by this paper
• Review article: Platelet abnormalities in diabetes mellitus

  2010cited by this paper
• Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus

  2010cited by this paper
• Endothelial function and dysfunction: testing and clinical relevance.

  2007cited by this paper
• Thrombin generation, a function test of the haemostaticthrombotic system

  2006cited by this paper
• Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study.

  2006cited by this paper
• Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5.

  2006cited by this paper
• Meal‐induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide

  2006cited by this paper
• The post‐prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart

  2004cited by this paper
• Soluble E-selectin in cardiovascular disease and its risk factors

  2003cited by this paper
• Type 1 and type 2 diabetic patients display different patterns of cellular microparticles.

  2002cited by this paper
• Platelets Expressing P-Selectin and Platelet-Derived Microparticles in Stored Platelet Concentrates Bind to PSGL-1 on Filtrated Leukocytes

  2000influential reference
• Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

  1999cited by this paper
• Platelet Abnormalities in Diabetes Mellitus

  1992cited by this paper

• Effect of Glucoraphanin on the Abundance of Nrf2 Regulated Genes Within Circulating Small Extracellular Vesicles: A Pilot Dietary Intervention

  2026cites this paper
• Acute Antiplatelet Effects of an Oleocanthal-Rich Olive Oil in Type II Diabetic Patients: A Postprandial Study

  2024cites this paper
• The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndrome

  2023cites this paper
• The Effect of Extracellular Vesicles on Thrombosis

  2022cites this paper
• Type 1 Diabetes and Associated Cardiovascular Damage: Contribution of Extracellular Vesicles in Tissue Crosstalk

  2021cites this paper
• Dietary modulation of large extracellular vesicles: the good and the bad for human health.

  2021cites this paper
• Primary prevention of cardiovascular diseases in diabetes mellitus: 2020 strategy

  2020cites this paper
• Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective.

  2020cites this paper
• Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2020cites this paper
• Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2019cites this paper
• Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes

  2019cites this paper
• DMSO_A_225761 2819..2828

  2019cites this paper